Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein H1 pseudogene 1 (HNRNPH1P1)
- Target
- HNRNPH1P1
- Molecular classification
- Pseudogene, Other
01
Overview
Heterogeneous nuclear ribonucleoprotein H1 pseudogene 1 (HNRNPH1P1) is a genomic region highly similar in sequence to the functional HNRNPH1 gene but contains disabling mutations that prevent the production of a functional RNA-binding protein. Classified as a pseudogene, HNRNPH1P1 is generally considered transcriptionally inactive and nonfunctional, lacking direct biological activity or therapeutic relevance. While some pseudogenes may be transcribed and influence gene regulation through mechanisms such as acting as competing endogenous RNAs, this is not described for HNRNPH1P1 in the current scientific literature. It is not recognized as a therapeutic target, biomarker, or disease-related gene, and no drugs are known to interact with it.
- Other names
- Heterogeneous nuclear ribonucleoprotein H1 (H) pseudogeneHNRNPH1P1
02
Biological functions
None established for HNRNPH1P1 directly as it is a noncoding pseudogene.(Note: Pseudogenes may have regulatory roles, e.g., in competing endogenous RNA networks, but direct biological function for HNRNPH1P1 is not currently characterized.)
03
Disease associations
None directly established for HNRNPH1P1.(General: Some pseudogenes have been implicated indirectly in cancer by acting as competing endogenous RNAs, but specific roles for HNRNPH1P1 are not reported in current literature.)
04
Safety considerations
None specific, as it is not a drug target.
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein H1 pseudogene 1 (HNRNPH1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein H1 pseudogene 1 (HNRNPH1P1).